Granules India Q3 FY2026: Revenue ₹1,387.94 Cr (vs ₹1,137.70 Cr YoY), PAT ₹150.21 Cr (vs ₹117.60 Cr YoY)
In Q3 FY2026 (quarter ended 31-Dec-25) Granules reported consolidated revenue from operations of ₹1,387.94 Cr and consolidated profit after tax of ₹150.21 Cr, both up materially YoY. Profit before tax was ₹202.23 Cr in Q3 FY2026, supported by higher sales and controlled operating costs despite elevated consultancy/air freight spend related to remediation. Key corporate actions in the quarter included consolidation of Senn Chemicals AG (contributed earlier in 9M) and acquisition of Granules Pharmaceuticals GmbH in November 2025. The company flagged ongoing remediation at the Gagillapur facility...
Total revenue from operations (Consolidated) Q3 FY2026
₹1,387.94 Cr
vs ₹1,137.70 Cr in Q3 FY2025
Profit after tax (Consolidated) Q3 FY2026
₹150.21 Cr
vs ₹117.60 Cr in Q3 FY2025
Profit before exceptional item and tax (Consolidated) Q3 FY2026
